Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test whether SU011248 has activity and is safe in patients with metastatic non-small cell lung cancer (NSCLC) who have failed a platinum-containing regimen and docetaxe...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06780085 · Carcinoma, Non-Small-Cell Lung
NCT07489066 · Carcinoma, Non-Small-Cell Lung, and more
NCT07230691 · Carcinoma, Non-Small-Cell Lung
NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more
NCT06855771 · Carcinoma, Non-Small-Cell Lung
Pfizer Investigational Site
Baltimore, Maryland
Pfizer Investigational Site
City of Saint Peters, Missouri
Pfizer Investigational Site
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions